Clinical Trials Directory

Trials / Unknown

UnknownNCT04606212

The Effects of Losartan on Emotion Processing

Losartan Effects on the Emotion Processing in Humans

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate the effect of losartan (50mg, single dose) on salience processing

Detailed description

In a double-blind, between-subject, placebo-controlled design the effects of a single dose of losartan (50mg) on salience processing in healthy participants will be examined. The study will adopt a previously validated visual Oddball fMRI paradigm, starting 90 minutes after subjects receive 50mg losartan or placebo. The task requires participants to respond to emotional and novelty oddballs. Neural activity will be assessed by the acquisition of functional magnetic resonance imaging (fMRI) data.

Conditions

Interventions

TypeNameDescription
DRUGLosartanadministration of losartan (50 mg) (oral)
DRUGPlacebo Oral Tabletadministration of placebo (oral)

Timeline

Start date
2020-10-10
Primary completion
2021-12-31
Completion
2022-03-31
First posted
2020-10-28
Last updated
2020-10-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04606212. Inclusion in this directory is not an endorsement.

The Effects of Losartan on Emotion Processing (NCT04606212) · Clinical Trials Directory